Mass Drug Administration for Scabies to Control Serious Bacterial Complications

Back to search results

Scabies is a major cause of morbidity in many developing countries and can lead to reduced quality of life and serious complications including systemic bacterial infection. Our SHIFT trial showed that one round of mass drug administration (MDA) using oral ivermectin reduced the scabies prevalence in a small island community in Fiji by 94%, one year after intervention. We will now take the next step towards the elimination of scabies as a global health problem by conducting a trial in a population of 140,000 people in Fiji to assess the impact of ivermectin MDA on secondary bacterial complications of scabies.

Apply Now
Supervisory team
John
Kaldor

Medicine
The Kirby Institute
Lucia
Romani

Medicine
The Kirby Institute
Andrew
Steer

Murdoch Children's Research Institute
external to UNSW
jkaldor@kirby.unsw.edu.au

Apply Now

Please start your application by taking the self assessment. Download the editable MS Word version or download the non-editable PDF version (best for Mac or mobile devices). Once the self assessment form is completed, save as a PDF and upload along with your application.

One file only.
50 MB limit.
Allowed types: gif jpg png bmp eps tif pict psd txt rtf html odf pdf doc docx ppt pptx xls xlsx xml avi mov mp3 ogg wav bz2 dmg gz jar rar sit svg tar zip.
If you have not done so, please complete the self assessment PDF as noted above.